Institutional Ownership
Kazia Therapeutics Ltd
CUSIP 48669G303SPONSORED ADSKZIAQ1 2026
13D / 13G Filings
2
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
11.0%
Max % of class reported
Institutional Holders
23
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
2 filings · latest Feb 17, 2026
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bleichroeder LP | 400.0K | $2.98M |
| 2 | Stonepine Capital Management, LLC | 345.2K | $2.57M |
| 3 | Point72 Asset Management, L.P. | 200.0K | $1.49M |
| 4 | Balyasny Asset Management L.P. | 193.1K | $1.44M |
| 5 | Flputnam Investment Management Co | 142.5K | $1.06M |
| 6 | Velan Capital Investment Management LP | 135.3K | $1.01M |
| 7 | Dauntless Investment Group, LLC | 79.8K | $594.0K |
| 8 | Sequoia Financial Advisors, LLC | 60.0K | $446.4K |
| 9 | Westside Investment Management, Inc. | 50.4K | $375.2K |
| 10 | Royal Bank Of Canada | 34.3K | $255.0K |